Pravin S. Iyer

Bellary Road, Hebbal
Bengaluru, KA 560024, India

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 19 publications

Discovery of aminopiperidine based potent & novel topoisomerase inhibitor with broad spectrum anti-bacterial activity.

Discovery of aminopiperidine based potent & novel topoisomerase inhibitor with broad spectrum anti-bacterial activity.

Journal: Bioorganic & medicinal chemistry letters

Published: March 26, 2024

Discovery of N-Cyano-sulfoximineurea Derivatives as Potent and Orally Bioavailable NLRP3 Inflammasome Inhibitors.

Discovery of N-Cyano-sulfoximineurea Derivatives as Potent and Orally Bioavailable NLRP3 Inflammasome Inhibitors.

Journal: ACS medicinal chemistry letters

Published: September 19, 2019

Scaffold Morphing To Identify Novel DprE1 Inhibitors with Antimycobacterial Activity.

Scaffold Morphing To Identify Novel DprE1 Inhibitors with Antimycobacterial Activity.

Journal: ACS medicinal chemistry letters

Published: July 29, 2019

Design and synthesis of functionalized piperazin-1yl-(E)-stilbenes as inhibitors of 17α-hydroxylase-C17,20-lyase (Cyp17).

Design and synthesis of functionalized piperazin-1yl-(E)-stilbenes as inhibitors of 17α-hydroxylase-C17,20-lyase (Cyp17).

Journal: Bioorganic & medicinal chemistry letters

Published: January 30, 2018

Discovery of Imidazo[1,2-a]pyridine Ethers and Squaramides as Selective and Potent Inhibitors of Mycobacterial Adenosine Triphosphate (ATP) Synthesis.

Discovery of Imidazo[1,2-a]pyridine Ethers and Squaramides as Selective and Potent Inhibitors of Mycobacterial Adenosine Triphosphate (ATP) Synthesis.

Journal: Journal of medicinal chemistry

Published: January 12, 2017

Design, synthesis, and evaluation of (2S,4R)-Ketoconazole sulfonamide analogs as potential treatments for Metabolic Syndrome.

Design, synthesis, and evaluation of (2S,4R)-Ketoconazole sulfonamide analogs as potential treatments for Metabolic Syndrome.

Journal: Bioorganic & medicinal chemistry letters

Published: June 25, 2016

Triaminopyrimidine is a fast-killing and long-acting antimalarial clinical candidate.

Triaminopyrimidine is a fast-killing and long-acting antimalarial clinical candidate.

Journal: Nature communications

Published: September 15, 2014

Synthesis and in vitro evaluation of novel 8-aminoquinoline-pyrazolopyrimidine hybrids as potent antimalarial agents.

Synthesis and in vitro evaluation of novel 8-aminoquinoline-pyrazolopyrimidine hybrids as potent antimalarial agents.

Journal: Bioorganic & medicinal chemistry letters

Published: August 13, 2014

Synthesis and biological evaluation of adamantane-based aminophenols as a novel class of antiplasmodial agents.

Synthesis and biological evaluation of adamantane-based aminophenols as a novel class of antiplasmodial agents.

Journal: Bioorganic & medicinal chemistry letters

Published: August 13, 2014

N-aryl-2-aminobenzimidazoles: novel, efficacious, antimalarial lead compounds.

N-aryl-2-aminobenzimidazoles: novel, efficacious, antimalarial lead compounds.

Journal: Journal of medicinal chemistry

Published: July 10, 2014

1,4-azaindole, a potential drug candidate for treatment of tuberculosis.

1,4-azaindole, a potential drug candidate for treatment of tuberculosis.

Journal: Antimicrobial agents and chemotherapy

Published: June 25, 2014

Aminoazabenzimidazoles, a novel class of orally active antimalarial agents.

Aminoazabenzimidazoles, a novel class of orally active antimalarial agents.

Journal: Journal of medicinal chemistry

Published: June 11, 2014

Showing 1-12 of 19

Last Updated: 09/26/2026